Sign in

CIK 0001867096 · Large accelerated filer

Xeris Biopharma Holdings, Inc.

Sign in to watch
Ticker
XERS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
871082097
Phone
844-445-5704
Business address
1375 WEST FULTON STREET, SUITE 1300, CHICAGO, IL, 60607
  1. CORRESP Other Correspondence Between Filers and SEC Staff
  2. UPLOAD Other SEC-generated Letter
  3. S-3 Offering Registration Statement
  4. UPLOAD Other SEC-generated Letter
  5. CORRESP Other Correspondence Between Filers and SEC Staff
  6. UPLOAD Other SEC-generated Letter
  7. CORRESP Other Correspondence Between Filers and SEC Staff
  8. UPLOAD Other SEC-generated Letter
  9. 424B5 Offering Prospectus
  10. 424B3 Offering Prospectus
  11. CORRESP Other Correspondence Between Filers and SEC Staff
  12. CORRESP Other Correspondence Between Filers and SEC Staff
  13. UPLOAD Other SEC-generated Letter
  14. UPLOAD Other SEC-generated Letter
  15. S-3 Offering Registration Statement
  16. S-3 Offering Registration Statement
  17. 424B3 Offering Prospectus
  18. CORRESP Other Correspondence Between Filers and SEC Staff
  19. UPLOAD Other SEC-generated Letter

Page 1 of 1 · 19 filings